北京大学肿瘤医院 胸部肿瘤内一科 副主任医师 擅长：肺癌、胸腺恶性肿瘤、胸膜间皮瘤等胸部实体肿瘤的个体化治疗及综合治疗，有丰富的临床经验。 社会兼职： 中国民族医药协会肿瘤学分会常委；中国老年保健协会胸部精准治疗分会常委；北京整合医学学会胸部精准治疗分会常委；北京市抗癌协会肺癌专业委员会常委；中国抗癌协会肺癌免疫治疗专委会委员 科研： 负责国家卫建委面上课题一项：广泛期小细胞肺癌免疫治疗疗效相关机制研究。 代表性论文： · Li, J., et al., Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis. BMC CANCER, 2020. 20(7931). · Li, J., et al., Efficacy and safety of pemetrexed maintenance chemotherapy for advanced non-small cell lung cancer in a real-world setting. JOURNAL OF THORACIC DISEASE, 2021. 13(3): p. 1813-1821. · Li, J., et al., Characteristics, survival, and risk factors of Chinese young lung cancer patients: the experience from two institutions. ONCOTARGET, 2017. 8(51): p. 89236-89244. · Li, J., et al.,Prognostic significance of micropapillary pattern and risk factors in patients with resected stage I lung adenocarcinoma and possible benefit of adjuvant therapy:a real-world muticenter study. Translational Lung Cancer Reseach,Vol14,No 7July 2025. · Li, J., et al., High risk occupational exposure and family history were risk factors in young lung cancer in Chinese. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016. 9(12): p. 23650-23657.